Clinical Trial Update: SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain [Phase 3]

View source ↗

Summary

Phase 3 extension study (SPIRIT EXTENSION) evaluating the efficacy and safety of relugolix in women with endometriosis-associated pain has completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Relugolix (Relugolix)

Snippet

Sponsor: Myovant Sciences GmbH | Conditions: Endometriosis | Phase 3 | Status: COMPLETED | Results posted: 2023-07-20